Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of September 23rd, we are planning to work on 17 projects, including:

Reimbursement

1. Working on the reimbursement strategy for medical technology in the urology field in England, France, and Germany
2. Initiating the work on reimbursement strategy for a number of in-vitro diagnostic tests in the obstetrics and gynecology field in Belgium, Bulgaria, the Czech Republic, France, Germany, Italy, Norway, Romania, and Switzerland
3. Initiating the work on reimbursement analysis for multiple technologies in obstetrics and gynecology in France, Germany, and Italy
4. Preparing materials for a live virtual educational seminar on market access challenges in Europe for one of the leading med tech companies in Europe
5. Starting a policy analysis project, including qualitative interviews in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 
6. Finalizing the work on the reimbursement strategy for a neurostimulator in the cardiology field in England, France, Germany, and Italy
7. Working on the reimbursement analysis for several technologies in ophthalmological, urological, and oncological fields in the Nordic region (Denmark, Finland, Norway, and Sweden)
8. Delivering the reimbursement analysis for an MRI technology in Germany
9. Delivering the reimbursement analysis for in-vitro diagnostic tests in the neonatal and neurovascular field in France and Italy

HEOR

1. Initiating work on the development of an HTA national submission dossier in Sweden
2. Initiating work on the development of a health economic model for neurovascular technology in Belgium, England, France, Germany, Italy, and Spain
3. Initiating work on the development of a health economic model for neuromonitoring technology in England
4. Initiating work on the Evidence Gap Analysis for a wound care product in France
5. Working on the update of adaptation of the global value dossiers for several technologies in cardio-renal and infectious disease space to European settings 
6. Implementing feedback from the client on the policy paper for diabetes technology 
7. Finalizing the Evidence Gap Analysis for a neurostimulator in the cardiology field in England, France, Germany, and Italy
8. Finalizing the work on adaptations of the health economic model for in-vitro diagnostic test in infectious disease area in France and Spain

Let us know if you need any market access or HEOR support for your medical technology in Europe.